These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 28751575

  • 1. Effects of Intranasal Insulin on Triglyceride-Rich Lipoprotein Particle Production in Healthy Men.
    Xiao C, Dash S, Stahel P, Lewis GF.
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1776-1781. PubMed ID: 28751575
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans.
    Xiao C, Bandsma RH, Dash S, Szeto L, Lewis GF.
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1513-9. PubMed ID: 22492091
    [Abstract] [Full Text] [Related]

  • 4. Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes.
    Nogueira JP, Maraninchi M, Béliard S, Padilla N, Duvillard L, Mancini J, Nicolay A, Xiao C, Vialettes B, Lewis GF, Valéro R.
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1039-44. PubMed ID: 22308041
    [Abstract] [Full Text] [Related]

  • 5. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans.
    Padilla N, Maraninchi M, Béliard S, Berthet B, Nogueira JP, Wolff E, Nicolay A, Bégu A, Dubois N, Grangeot R, Mattei C, Vialettes B, Xiao C, Lewis GF, Valéro R.
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2330-7. PubMed ID: 25104797
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans.
    Xiao C, Dash S, Morgantini C, Lewis GF.
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1056-62. PubMed ID: 23471231
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production.
    Duez H, Lamarche B, Uffelman KD, Valéro R, Szeto L, Lemieux S, Cohn JS, Lewis GF.
    J Clin Endocrinol Metab; 2008 May; 93(5):1722-9. PubMed ID: 18285418
    [Abstract] [Full Text] [Related]

  • 10. Dietary medium-chain triglyceride supplementation has no effect on apolipoprotein B-48 and apolipoprotein B-100 kinetics in insulin-resistant men.
    Tremblay AJ, Lamarche B, Labonté MÈ, Lépine MC, Lemelin V, Couture P.
    Am J Clin Nutr; 2014 Jan; 99(1):54-61. PubMed ID: 24172309
    [Abstract] [Full Text] [Related]

  • 11. Differential Effects of Estrogen and Progestin on Apolipoprotein B100 and B48 Kinetics in Postmenopausal Women.
    Lamon-Fava S, Diffenderfer MR, Barrett PHR, Wan WY, Postfai B, Nartsupha C, Dolnikowski GG, Schaefer EJ.
    Lipids; 2018 Feb; 53(2):167-175. PubMed ID: 29537647
    [Abstract] [Full Text] [Related]

  • 12. Effects of intranasal insulin on endogenous glucose production in insulin-resistant men.
    Xiao C, Dash S, Stahel P, Lewis GF.
    Diabetes Obes Metab; 2018 Jul; 20(7):1751-1754. PubMed ID: 29536605
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of acute hyperglucagonemia on hepatic and intestinal lipoprotein production and clearance in healthy humans.
    Xiao C, Pavlic M, Szeto L, Patterson BW, Lewis GF.
    Diabetes; 2011 Feb; 60(2):383-90. PubMed ID: 20980459
    [Abstract] [Full Text] [Related]

  • 17. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
    Hogue JC, Lamarche B, Deshaies Y, Tremblay AJ, Bergeron J, Gagné C, Couture P.
    Metabolism; 2008 Feb; 57(2):246-54. PubMed ID: 18191056
    [Abstract] [Full Text] [Related]

  • 18. Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production.
    Chirieac DV, Chirieac LR, Corsetti JP, Cianci J, Sparks CE, Sparks JD.
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1003-11. PubMed ID: 11052954
    [Abstract] [Full Text] [Related]

  • 19. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
    Hooper AJ, Heeks L, Robertson K, Champain D, Hua J, Song S, Parhofer KG, Barrett PH, van Bockxmeer FM, Burnett JR.
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
    [Abstract] [Full Text] [Related]

  • 20. Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations.
    Dash S, Xiao C, Morgantini C, Koulajian K, Lewis GF.
    Diabetes; 2015 Mar; 64(3):766-74. PubMed ID: 25288674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.